Clinical Trial Update: CUE-102 in Recurrent Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for CUE-102 in recurrent glioblastoma showing the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• CUE-102

Snippet

Sponsor: David Reardon, MD | Conditions: Recurrent Glioblastoma, Glioblastoma | Phase 1 | Status: RECRUITING